Replies to post #59478 on NorthWest Biotherapeutics Inc (NWBO)

[DoGood_DoWell]

That is your opinion but many of us longs don't share it. Putting words in people's mouths is not the best way to make a convincing argument. Linda is a big shareholder. If she were to destroy the company, who would Cognate manufacture for? How would all of the patents for IP and manufacturing become profitable? By functioning together as previously mentioned, the value of the company will be much greater once the trials are completed and hopefully products approved. But you are in some kind of weird fantasy land if you think Cognate should just keep sucking it up and not be paid while waiting for NWBO to complete the trials. Maybe you would like it better if a competitor owned Cognate?

[Poor Man -]

don't like it when it appears the NWBO is given the short end of the stick

It's a very legitimate question/concern. Ideally, any transactions between the two companies should be contracted at arms length to avoid any gaming between the two entities. There's obviously alignment of interests between the interest of common shareholders of NWBO and the fund investors in both companies, but it's not a perfect alignment.

Since Cognate as a private company has no direct access to the public markets it has to fund the services it provides (sells) to NWBO in some way. That happens either through the payment in the form of common shares or in cash, which is raised by NWBO through its capital raises.

There is nothing I see that suggests that NWBO is being disadvantaged vis`a vis Cognate. But I believe that will be addressed in the coming investigative report.